Document Detail

Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy.
MedLine Citation:
PMID:  21396217     Owner:  NLM     Status:  In-Data-Review    
We describe the efficacy and outcome of standardised second-line anti-tuberculosis (TB) medications during pregnancy. Treatment outcomes of five pregnant women with documented multidrug-resistant TB (MDR-TB) referred to the National Research Institute of Tuberculosis and Lung Diseases from 2003 to 2009 were analysed in two categories, maternal and neonatal. Patients became pregnant during treatment for MDR-TB without any changes in their anti-tuberculosis regimen. None of them had any adverse effects during pregnancy and delivery. No adverse effects were observed in mothers or neonates. The treatment of MDR-TB during pregnancy with a standardised second-line regimen in this study population was safe, with an acceptable rate of treatment success.
P Tabarsi; A Moradi; P Baghaei; M Marjani; M Shamaei; N Mansouri; E Chitsaz; P Farnia; D Mansouri; M Masjedi; A Velayati
Related Documents :
21091927 - Mycoplasmas in pregnancy.
10731727 - Sonographic measurements of fetal parts to predict pulmonary maturity among twins and s...
803787 - Fetal maturity: biochemical analyses of amniotic fluid.
7193607 - Lecithin-sphingomyelin ratio in fetal membranes during gestation.
22284767 - Association between the serum levels of relaxin and responses to the active straight le...
24336677 - First-trimester levels of pregnancy-associated plasma protein a2 (papp-a2) in the mater...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease     Volume:  15     ISSN:  1815-7920     ISO Abbreviation:  Int. J. Tuberc. Lung Dis.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9706389     Medline TA:  Int J Tuberc Lung Dis     Country:  France    
Other Details:
Languages:  eng     Pagination:  547-50     Citation Subset:  IM    
Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Diseases, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia.
Next Document:  Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea.